Self-pay private hospital admissions reach record high as patients weigh paying direct against PMI

Self-pay admissions to UK private hospitals reached a record high in the first quarter of 2026, as more patients chose to fund individual procedures directly rather than use private medical insurance.

Latest figures from the Private Healthcare Information Network (PHIN) show self-pay admissions increased by 7.7% compared with Q1 2025, reaching their highest recorded quarterly level.

At the same time, admissions funded through private medical insurance fell by 2.6%.

Overall private hospital activity remained broadly stable at 247,495 reported inpatient and day-case admissions, with insurance funding 69% of admissions and self-pay accounting for 31%.

The figures do not necessarily represent a wholesale move away from insurance, however.

Much of the increase in self-pay activity was concentrated in specific procedures and age groups. Cataract surgery alone accounted for almost half of the overall increase in self-pay admissions.

That distinction matters when comparing the two ways of accessing private treatment.

Self-pay is largely about paying for a known healthcare need. Private medical insurance is primarily about transferring some of the financial risk of unknown future eligible treatment to an insurer.

What does self-pay private healthcare mean?

Self-pay means exactly what it sounds like.

Instead of claiming through an insurance policy, the patient pays the private hospital, consultant or diagnostic provider directly.

That might involve paying for:

  • a private GP appointment;
  • a specialist consultation;
  • an MRI or CT scan;
  • cataract surgery;
  • a hip or knee replacement;
  • physiotherapy;
  • diagnostic investigations; or
  • another private procedure.

There is no insurance claim and therefore no insurance underwriting decision determining whether that particular treatment is covered.

The patient simply pays the agreed cost.

That can make self-pay particularly attractive where somebody already knows what medical care they need.

Why are more people paying directly?

The Q1 figures suggest self-pay remains an important part of the private healthcare market, but the increase was not spread equally across all types of treatment.

PHIN found that cataract surgery accounted for 46% of the total increase in self-pay admissions.

Cataract admissions across all funding methods increased by 13% to 22,805, while self-funded cataract procedures increased by 21%.

Older patients accounted for much of the additional self-pay activity.

That suggests at least part of the record figure reflects people making a specific decision to fund a relatively defined procedure rather than necessarily deciding to replace NHS care with private healthcare generally.

A patient may decide to self-pay because:

  • they face a long local NHS wait;
  • the procedure has a reasonably predictable cost;
  • they want a particular consultant or hospital;
  • they have savings available;
  • they do not have PMI;
  • their insurance excludes the condition; or
  • the problem existed before they considered buying insurance.

That final point is particularly important.

Buying PMI after you need treatment may not solve the problem

Someone who develops a medical problem can understandably start investigating private medical insurance after discovering that NHS treatment may involve a long wait.

But PMI is generally intended primarily to insure against new eligible medical conditions that arise after cover begins.

It is not normally designed to pay for treatment somebody already knows they need.

A pre-existing condition can include more than a formal diagnosis.

Symptoms, previous medical advice, medication, referrals and investigations can all potentially be relevant.

Our guide to private medical insurance with pre-existing conditions explains why somebody can still be accepted for PMI while the particular condition they already have remains excluded.

For someone already waiting for cataract surgery, an MRI or another procedure, self-pay may therefore be a more realistic private option than buying new insurance specifically for that existing problem.

Self-pay and PMI solve different financial problems

The simplest distinction is:

Self-pay
You keep the healthcare financial risk yourself and pay when you need treatment.

Private medical insurance
You pay regular premiums to transfer some future eligible healthcare costs to an insurer.

Neither approach is automatically better.

Suppose someone needs an investigation that will cost £600.

They may prefer simply to pay £600 rather than maintain an insurance policy for years.

But consider a different person who unexpectedly develops a new condition requiring:

  • multiple specialist consultations;
  • several scans;
  • surgery;
  • a private hospital stay;
  • physiotherapy; and
  • follow-up treatment.

The total bill could be much larger and harder to predict.

That uncertainty is where insurance can become valuable.

Our guide to what private medical insurance is and whether it may be worth it explains why PMI is better viewed as protection against uncertain future medical costs rather than a private-healthcare subscription.

Self-pay can offer certainty for a defined procedure

One of the attractions of self-pay is that some private providers offer fixed-price packages for common procedures.

If somebody already knows that they need cataract surgery, for example, they may be able to compare:

  • hospitals;
  • consultants;
  • waiting times;
  • package prices; and
  • what follow-up care is included.

That can make the financial decision relatively tangible.

Instead of paying an insurance premium indefinitely, the patient knows they are buying one particular piece of healthcare.

But the phrase “fixed price” still needs careful examination.

Patients should establish exactly what the quoted amount includes.

Compare the whole self-pay package

A headline procedure price may not necessarily cover every cost associated with treatment.

Before agreeing to self-funded treatment, it is worth asking whether the price includes:

  • consultant fees;
  • anaesthetist fees;
  • hospital charges;
  • diagnostic tests;
  • pathology;
  • medication;
  • implants or prostheses;
  • physiotherapy;
  • follow-up appointments; and
  • treatment of complications.

Patients should also ask what happens if the procedure becomes more complicated than expected.

For example:

What happens if another scan is required?

What happens if an overnight stay becomes necessary?

What if a complication requires further treatment?

A £4,000 package that genuinely includes most foreseeable costs is a different proposition from a £3,500 headline price surrounded by additional charges.

Diagnostics can be particularly suitable for selective self-pay

Some people do not want to move their entire healthcare into the private sector.

They simply want to speed up one part of the pathway.

For example:

GP → private MRI → diagnosis → back to NHS treatment

That can sometimes make selective self-pay attractive.

Someone might decide that paying several hundred pounds for a scan is worthwhile if it gives them clarity sooner, even though they would not want to fund a £15,000 operation privately.

Conversely, somebody with PMI may have private diagnostic imaging covered as part of their policy.

Our guide to whether PMI covers MRI and CT scans explains why diagnostic cover can be one of the more important parts of a policy for people concerned about access.

This demonstrates why the choice does not always have to be NHS or private.

Patients can sometimes move between the two systems at different stages of their care.

PMI can be more useful for unpredictable future treatment

Private medical insurance becomes a different proposition when the healthcare need is unknown.

Someone buying PMI today does not know whether they will need:

  • an orthopaedic consultation;
  • cancer treatment;
  • an MRI;
  • surgery;
  • mental-health treatment;
  • physiotherapy; or
  • nothing at all.

They pay a premium because of that uncertainty.

If an eligible new condition arises, the policy may meet private treatment costs that would otherwise have to be funded personally.

But the cover is still governed by the contract.

Our guide to what private medical insurance covers and what it doesn't explains the distinction between eligible acute treatment and areas commonly excluded or treated differently.

PMI should not be thought of as unlimited private healthcare.

A PMI claim is still subject to limits and authorisation

A person with insurance cannot necessarily choose any private service and expect the insurer to pay the bill.

Policies can differ over:

  • outpatient limits;
  • diagnostic benefits;
  • hospital networks;
  • consultant recognition;
  • mental-health treatment;
  • cancer cover;
  • excesses;
  • underwriting;
  • exclusions; and
  • claim authorisation.

That means £100 per month spent on one PMI policy may buy something quite different from £100 spent with another provider.

Our guide to comparing private medical insurance providers explains why the monthly premium should never be considered in isolation.

Excesses create a middle ground between insurance and self-pay

PMI itself can also involve an element of self-funding.

An excess is the amount the policyholder agrees to contribute towards eligible treatment when making a claim.

For example:

Treatment cost: £4,000
Policy excess: £250

The customer may pay the £250 excess and the insurer meet the remaining eligible cost, subject to the policy terms.

Choosing a larger excess can reduce the regular insurance premium because the policyholder retains more of the financial risk.

Our guide to how PMI excess works explains why excess choice effectively determines how much healthcare risk you keep yourself.

Someone comfortable paying the first £1,000 of a private healthcare bill might deliberately select a high excess and use insurance primarily to protect against larger costs.

That can create a middle ground between paying everything yourself and expecting insurance to meet smaller medical bills.

A cheaper PMI policy may restrict hospital choice

Hospital access is another important difference.

A self-pay patient can generally approach whichever private provider is willing to offer the treatment at a price they accept.

An insured patient needs to work within the terms of their policy.

Some PMI policies include broad national hospital networks.

Others reduce premiums through:

  • restricted hospital lists;
  • local hospital networks;
  • guided consultant arrangements; or
  • NHS wait options.

These may be perfectly appropriate, but the trade-off needs to be understood.

A customer buying PMI because they want access to one particular private hospital should confirm that it is actually included.

Our guide to how much private medical insurance costs explains how hospital choice, excess and benefit levels can all affect the premium.

Insurance also has an ongoing cost

Self-pay carries the obvious risk that a large unexpected healthcare bill has to be met from savings or income.

PMI creates a different financial commitment.

Premiums are paid whether or not the policyholder makes a claim.

They can also change at renewal.

Factors influencing future premiums can include:

  • age;
  • medical inflation;
  • claims;
  • no-claims discount arrangements;
  • insurer pricing;
  • hospital costs;
  • location; and
  • the level of cover selected.

Someone comparing a £4,000 self-pay operation with a £100-a-month insurance premium should therefore be careful with the maths.

Paying £100 a month is not simply buying that £4,000 procedure for £1,200 a year.

The insurance is protecting against the possibility of a range of eligible future claims.

Likewise, somebody who pays £4,000 for one procedure has not bought protection against the next medical problem.

They are fundamentally different financial arrangements.

Self-pay growth does not mean PMI is disappearing

The latest PHIN figures are particularly interesting because self-pay admissions reached a record high while insurance-funded admissions declined.

But that should not be interpreted as proof that consumers are abandoning private medical insurance.

Insurance still accounted for 69% of UK private hospital admissions in Q1 2026, compared with 31% for self-pay.

PHIN also reported that the increase in self-pay was heavily influenced by specific ophthalmology procedures.

The overall number of private admissions was only fractionally higher than a year earlier.

The more useful conclusion is that the private healthcare market contains two distinct funding behaviours.

Some people want to insure against future treatment costs.

Others are prepared to buy specific private treatment when they need it.

And some people may do both at different stages of their lives.

Which route might suit which situation?

Self-pay may be worth considering where:

  • there is a known, defined treatment need;
  • the likely cost is manageable;
  • a newly purchased PMI policy would exclude the condition;
  • only occasional private treatment is expected; or
  • the patient wants to choose and purchase a particular service directly.

PMI may be more attractive where:

  • protection against unknown future health problems is important;
  • potentially large treatment costs would be difficult to self-fund;
  • faster private diagnosis is valued;
  • regular premiums are comfortably affordable; and
  • the policy's exclusions and limitations are understood.

Neither removes the need for the NHS.

Emergency treatment, long-term chronic care and many routine services will continue to depend heavily on NHS provision even for people who use private healthcare.

The right comparison starts with the risk

The record level of self-pay activity shows that more patients are willing to make active decisions about how they access healthcare.

But the choice should not begin with:

“Which is cheaper — PMI or self-pay?”

The better questions are:

Do I already need treatment, or am I protecting against something that might happen in future?

Could I comfortably pay several thousand pounds if I needed private treatment?

Would I prefer the certainty of an insurance premium?

What conditions would the insurance actually cover?

How much financial risk am I comfortable keeping myself?

Those questions reveal the real difference.

Self-pay gives somebody the ability to purchase private healthcare when a known need arises.

PMI provides insurance against eligible unknown future needs, within the limits of a policy.

For anyone considering the insurance route, our PMI Explained guide provides a starting point for understanding cover, exclusions and underwriting before comparing quotes.

The growth in self-pay does not demonstrate that one method is better than the other.

It demonstrates that increasingly, patients are making a deliberate choice between waiting, paying directly and insuring the risk.

Source: Private Healthcare Information Network (PHIN), Private healthcare market update: September 2026 – United Kingdom, covering Q1 2026 activity.